1. Home
  2. SIDU vs AGEN Comparison

SIDU vs AGEN Comparison

Compare SIDU & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

N/A

Current Price

$1.93

Market Cap

243.4M

ML Signal

N/A

Logo Agenus Inc.

AGEN

Agenus Inc.

N/A

Current Price

$7.16

Market Cap

274.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIDU
AGEN
Founded
2012
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.4M
274.8M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
SIDU
AGEN
Price
$1.93
$7.16
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
3.1M
977.6K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
66.94
100.00
EPS
N/A
0.96
Revenue
$3,383,878.00
$42,877,086.00
Revenue This Year
$171.29
$107.63
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.23
Revenue Growth
N/A
89.95
52 Week Low
$0.63
$2.71
52 Week High
$6.79
$8.85

Technical Indicators

Market Signals
Indicator
SIDU
AGEN
Relative Strength Index (RSI) 36.53 47.99
Support Level $1.73 $2.97
Resistance Level $3.12 $8.64
Average True Range (ATR) 0.11 0.49
MACD -0.03 -0.20
Stochastic Oscillator 4.65 25.27

Price Performance

Historical Comparison
SIDU
AGEN

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: